High plasma immunoreactive leptin level in essential hypertension.
about
A teleological view of obesity, diabetes and hypertension.The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.Insulin resistance and hypertension.Physiological roles of the leptin endocrine system: differences between mice and humans.Mouse models of the metabolic syndrome.Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanismsLinkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese.Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findingsPrevalence of metabolic syndrome in a cohort of Chinese schoolchildren: comparison of two definitions and assessment of adipokines as components by factor analysis.Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.Mechanical stretch-induced vascular hypertrophy occurs through modulation of leptin synthesis-mediated ROS formation and GATA-4 nuclear translocationStructural and functional evidence supporting a role for leptin in central neural pathways influencing blood pressure in rats.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Obesity and eye diseases.Leptin-induced endothelial dysfunction in obesity.Higher leptin is associated with hypertension: the Multi-Ethnic Study of AtherosclerosisLeptin and cardiovascular disease: response to therapeutic interventionsInflammation and hypertension in rheumatoid arthritisAssociation between adipocytokines and insulin resistance in Indian hypertensive patients.Leptin modulates electrophysiological characteristics and isoproterenol-induced arrhythmogenesis in atrial myocytes.The effect of vitamin D administration on serum leptin and adiponectin levels in end-stage renal disease patients on hemodialysis with vitamin D deficiency: A placebo-controlled double-blind clinical trialSympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsGhrelin and leptin pathophysiology in chronic kidney disease.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system.Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.Gastrointestinal Tract: a Promising Target for the Management of Hypertension.Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension.Leptin increases endothelin type A receptor levels in vascular smooth muscle cells.Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.Pathophysiological role of leptin in obesity-related hypertension.Calcineurin/NFAT Activation-Dependence of Leptin Synthesis and Vascular Growth in Response to Mechanical StretchInflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study.Evaluation of leptin and leptin receptor gene 3' UTR polymorphisms in essential hypertension.Human leptin stimulates systemic nitric oxide production in the rat.Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.Association between serum leptin levels and 24-hour blood pressure in obese women.
P2860
Q30356368-790D7A0A-A8C6-4B97-9134-330563FFEDB8Q33572275-F65F45C0-1AB7-4C37-A8DE-D0F4484124BCQ33697707-C6C6E428-CE5D-405B-BD31-EF62CAB76B16Q33828756-F1FD7559-5E23-437C-ACEB-B141BA5C8A5BQ33849244-1FF88E04-4F63-4125-AADE-CEB84C477AD0Q33889401-629DCC59-7EB2-471A-A9C6-86F3AEF94F9EQ34012227-761D5EB4-C98D-4F47-AA08-9EF491556542Q34285367-2315DF7B-9BD5-483C-9A87-CE825F92C0BBQ34628695-AC007478-871E-4FFC-916E-B32B7D6D8C7FQ35660142-58A443CB-2F00-4FBF-9256-B2030A65B190Q36015883-38BF0337-2BA1-4268-8365-895B55576AC1Q36192201-6A233A99-FE64-4A43-A3C2-5D58558AC9A8Q36232623-8E344043-A792-4A97-9D1E-01A0A67AD43AQ36682368-0F45F8F8-F094-4E11-A5E5-3EF2F92177C3Q36758799-164A78EC-8A17-458D-8A03-FBE2B09CF711Q36995143-33EDF294-9943-4147-9725-A085132CF8E6Q37076269-26E53A34-70FB-493A-96DA-3662EBE78E28Q37198354-523A8011-E1BF-4941-B814-E9D41BE890A0Q37281848-7F33D967-33B2-4155-AF2B-D2D5A1805F4BQ37387400-AE9259A8-26D3-40B8-9EC0-92348603AD64Q37425695-CBA8A749-A862-46BB-B486-B365F327762AQ37436728-1DB4C2DE-8E38-474B-8E2C-F2CBC648FDDCQ37518344-8DA6319B-B9EC-42E2-A98B-4E9516D008D2Q38066384-C62F7FD7-55DA-4988-9467-29BF2D68404EQ38071133-3B80E580-9602-412B-8FD0-4DB65EB7BF27Q38080812-4CA8AA69-68DD-47E5-A639-EAE822D10ED6Q38200787-ABAE70A6-6EDF-4450-995F-D1D263E5B495Q38444730-64CC5C0A-B95D-47A9-B651-8CC8CA495330Q39204264-3CA723FD-13E0-4C83-939B-AC44069E9E36Q39547921-F2A70BDF-C663-4300-9081-0F8DE3D89259Q39805097-A2608696-2BE1-4426-9925-8257155E2B91Q40040823-00C95230-528D-4AE5-BF0B-4226BDFFBD50Q40079093-2BAE5B01-7964-4736-8695-9C907379708FQ40437354-A07ABBFD-9995-42A0-BBE4-7C9EFD6694B8Q41211026-2DA4F4D7-46DD-414D-8E30-7869670E388FQ43720735-F6D3E440-E48C-460C-ADAA-5622B78C1CD8Q44001086-1D0E15BD-1C1F-4AAB-A767-CABE7FC2EDEAQ44133918-175AE2AE-2B75-4DA5-9B9E-821C94253F7EQ44278786-D55A7AFA-71E5-4389-9154-5F77CF614896Q44400053-9E24C99A-7124-41B8-8F26-98AA65C16AEC
P2860
High plasma immunoreactive leptin level in essential hypertension.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
High plasma immunoreactive leptin level in essential hypertension.
@en
type
label
High plasma immunoreactive leptin level in essential hypertension.
@en
prefLabel
High plasma immunoreactive leptin level in essential hypertension.
@en
P2093
P1476
High plasma immunoreactive leptin level in essential hypertension.
@en
P2093
Higashiura K
Miyazaki Y
Murakami H
Shimamoto K
P304
P356
10.1016/S0895-7061(97)00310-5
P433
P577
1997-10-01T00:00:00Z